Live Q&A: Health Equity in the Context of New and Emerging Therapies for Hemophilia

Statement of Need

People with mild or moderate hemophilia may struggle to get prophylactic treatment because their disease severity classification does not always match their bleeding symptoms. Additionally, racial and ethnic minority groups with hemophilia often face systemic and socioeconomic circumstances that prevent them from accessing optimized care. It is important for healthcare providers to recognize the barriers to appropriate hemophilia treatment and take actionable steps to overcome institutional, social, economic, and other roadblocks so that all patients can benefit from advances in therapy.

In this 30-minute CME Outfitters Live Q&A, experts in hemophilia will discuss questions related to new and emerging therapies that address health equity regarding hemophilia subtype as well as strategies to factor in racial and ethnic equity in the care of patients with hemophilia.

Learning Objectives

At the conclusion of this activity, learners will be able to better:

Evaluate opportunities for new and emerging therapies that address health equity regarding hemophilia subtype
Implement strategies to factor in racial and ethnic equity in the care of patients with hemophilia

Financial Support

Supported by an educational grant from Novo Nordisk, Inc.

Target Audience

Hematologists, hematologist/oncologists, physician associates (PAs), nurse practitioners (NPs), and nurses

Credit Information

Jointly Accredited Provider

In support of improving patient care, CME Outfitters, LLC, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Physicians (ACCME) 0.5

CME Outfitters, LLC, designates this live activity for a maximum of 0.50 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses (ANCC) 0.5

This activity is designated for 0.50 contact hours.

California Residents: This continuing nursing education activity was approved by the California Board of Registered Nursing. CME Outfitters, LLC’s provider number is CEP15510.

Note to Nurse Practitioners: The content of this CNE activity pertains to Pharmacology.

Pharmacists (ACPE) 0.5

This application-based activity is approved for 0.50 contact hours ( 0.05 CEUs) of continuing pharmacy credit (JA0007185-0000-24-046-L01-P).

Physician Assistants (AAPA): 0.5

CME Outfitters, LLC, has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 0.50 AAPA Category 1 CME credits. Approval is valid until 11/19/2024. PAs should only claim credit commensurate with the extent of their participation.

Interprofessional (IPCE) 0.5

This activity was planned by and for the healthcare team, and learners will receive 0.50 Interprofessional Continuing Education Credit for learning and change.

Disclosure Declaration

Ms. Bloomberg reports the following financial relationships:

Advisory Board: Genentech, Inc.; Novo Nordisk; Pfizer Inc.; Sanofi; and Takeda Pharmaceuticals U.S.A., Inc.

Speakers Bureau: Bayer; Genentech, Inc.; Novo Nordisk; and Sanofi

The following individuals have no financial relationships to disclose:

Thomas Mitchell, MSW (Planning Committee)
Warren Beckman (Planning Committee)
Scott J. Hershman, MD, FACEHP, CHCP (Planning Committee)
Sandra Caballero, PharmD (Planning Committee)
Sharon Tordoff (Planning Committee)

Questions about this activity?

Call us at 877.CME.PROS (877.263.7767).

SNQ-239-091924-68